Picture of Cardiol Therapeutics logo

CRDL Cardiol Therapeutics News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

Brief: Cardiol Announces Positive Study Results Showing Cardioprotective Effects Of Subcutaneously Administered Cannabidiol

Oct 10 (Reuters) - Cardiol Therapeutics Inc  CRDL.TO :
    * CARDIOL - ANNOUNCES POSITIVE STUDY RESULTS SHOWING
CARDIOPROTECTIVE EFFECTS OF SUBCUTANEOUSLY ADMINISTERED
CANNABIDIOL


Further company coverage:  CRDL.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cardiol Therapeutics

See all news